CryoPort (NASDAQ:CYRX) Share Price Crosses Above Two Hundred Day Moving Average – What’s Next?

CryoPort, Inc. (NASDAQ:CYRX)’s share price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $10.60 and traded as high as $15.04. CryoPort shares last traded at $14.76, with a volume of 443,402 shares.

Analyst Upgrades and Downgrades

CYRX has been the subject of a number of analyst reports. Guggenheim upped their price objective on shares of CryoPort from $11.00 to $12.00 and gave the company a “buy” rating in a research report on Tuesday, May 5th. Wall Street Zen raised CryoPort from a “sell” rating to a “hold” rating in a research report on Monday, May 11th. Jefferies Financial Group set a $13.50 price target on CryoPort in a research note on Monday, June 8th. BTIG Research increased their price target on CryoPort from $15.00 to $17.00 and gave the company a “buy” rating in a report on Tuesday, May 5th. Finally, Needham & Company LLC raised their price objective on CryoPort from $13.00 to $15.00 and gave the company a “buy” rating in a research note on Tuesday, May 5th. Eight investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat, CryoPort currently has an average rating of “Moderate Buy” and a consensus price target of $15.11.

CryoPort Trading Down 0.1%

The stock has a market capitalization of $743.90 million, a P/E ratio of 10.93 and a beta of 1.90. The stock’s 50 day simple moving average is $13.20 and its 200 day simple moving average is $10.60.

CryoPort (NASDAQ:CYRX) last released its earnings results on Monday, May 4th. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.03). The company had revenue of $47.80 million during the quarter, compared to the consensus estimate of $44.86 million. CryoPort had a negative return on equity of 7.92% and a net margin of 41.57%. On average, sell-side analysts expect that CryoPort, Inc. will post -0.85 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO Robert Stefanovich sold 169,427 shares of the business’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $16.27, for a total value of $2,756,577.29. Following the completion of the sale, the chief financial officer directly owned 109,850 shares of the company’s stock, valued at $1,787,259.50. The trade was a 60.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Ramkumar Mandalam sold 23,214 shares of the company’s stock in a transaction that occurred on Monday, June 8th. The shares were sold at an average price of $15.44, for a total value of $358,424.16. Following the sale, the director owned 67,894 shares in the company, valued at $1,048,283.36. The trade was a 25.48% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 227,641 shares of company stock worth $3,622,515. Corporate insiders own 10.10% of the company’s stock.

Institutional Investors Weigh In On CryoPort

Several institutional investors and hedge funds have recently made changes to their positions in CYRX. LPL Financial LLC increased its holdings in shares of CryoPort by 6.6% during the fourth quarter. LPL Financial LLC now owns 23,306 shares of the company’s stock valued at $224,000 after purchasing an additional 1,433 shares during the period. The Manufacturers Life Insurance Company lifted its holdings in CryoPort by 9.4% in the second quarter. The Manufacturers Life Insurance Company now owns 18,178 shares of the company’s stock worth $136,000 after purchasing an additional 1,557 shares during the period. State of Wyoming grew its position in CryoPort by 30.2% in the 2nd quarter. State of Wyoming now owns 14,218 shares of the company’s stock valued at $106,000 after buying an additional 3,301 shares in the last quarter. Basepoint Wealth LLC bought a new position in CryoPort in the 4th quarter valued at about $34,000. Finally, BNP Paribas Financial Markets increased its stake in CryoPort by 55.2% during the 3rd quarter. BNP Paribas Financial Markets now owns 11,880 shares of the company’s stock valued at $113,000 after buying an additional 4,225 shares during the period. 92.90% of the stock is owned by institutional investors and hedge funds.

CryoPort Company Profile

CryoPort, Inc (NASDAQ: CYRX) is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.

CryoPort’s product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.